Role of endogenous TNF-α in cardiomyocyte apoptosis induced by bacteria lipoprotein and the protective effect of IL-10

European Journal of Inflammation

Volumn 13, Issue 2, 2015, Pages 117-125

  Li, Zhicai ^a   Zhou, Jing ^b   Zhu, Dongmei ^b   Zhang, Qian ^b   Huang, Min ^b   Han, Yi ^b   Zhou, Suming ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Bacteria lipoprotein; Interleukin 10; Neonatal rat cardiomyocyte; Tumor necrosis factor

Indexed keywords

BACTERIAL LIPOPROTEIN; BACTERIAL PROTEIN; CASPASE 3; LIPOPROTEIN; PROTEIN BAX; PROTEIN BCL 2; RECOMBINANT INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; ATTENUATION; CELL MEMBRANE PERMEABILITY; CELL NUCLEUS; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG INHIBITION; ENZYME ACTIVATION; HEART MUSCLE CELL; IN VITRO STUDY; IN VIVO STUDY; NEWBORN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RECEPTOR DOWN REGULATION; SEPSIS;

EID: 84941193473     PISSN: 1721727X     EISSN: 20587392     Source Type: Journal    
DOI: 10.1177/1721727X15597363     Document Type: Article

References (20)

1. Angus DC, Linde-Zwirble WT, Lidicker J, et al. (2001) Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Critical Care Medicine 29: 1303-1310.
2. Dombrovskiy VY, Martin AA, Sunderram J, et al. (2007) Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: A trend analysis from 1993 to 2003. Critical Care Medicine 35: 1244-1250.
3. Viellard-Baron A, Caille V, Charron C, et al. (2008) Actual incidence of global left ventricular hypokinesia in adult septic shock. Critical Care Medicine 36: 1701-1706.
4. Jing Zhou, Min Huang, Li-Qing Bi, et al. (2012) Bacterial lipoprotein tolerance attenuates cardiac dysfunction in septic mice. Central European Journal of Immunology 37: 209-220.
5. Parrillo JE, Burch C, Shelhamer JH, et al. (1985) A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. Journal of Clinical Investigation 76: 1539-1553.
6. Chung ES, Packer M, Lo KH, et al. (2003) Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor, in patients with moderate-tosevere heart failure: Results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial. Circulation 107: 3133-3140.
7. Mann DL, McMurray JJ, Packer M, et al. (2004) Targeted anticytokine therapy in patients with chronic heart failure: Results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). Circulation 109: 1594-1602.
8. Reinhart K, Wiegand-Lohnert C, Grimminger F, et al. (1996) Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: A multicenter, randomized, placebo-controlled, dose-ranging study. Critical Care Medicine 24: 733-742.
9. Reinhart K and Karzai W (2001) Anti-tumor necrosis factor therapy in sepsis: Update on clinical trials and lessons learned. Critical Care Medicine 29: S121-125.
10. Xiang Zhou, Yanhui Sheng, Rong Yang, et al. (2001) Nicotine promotes cardiomyocyte apoptosis via oxidative stress and altered apoptosis-related gene expression. Cardiology 115: 243-250.
11. Takasaki W, Kajino Y, Kajino K, et al. (1997) Structure-based design and characterization of exocyclic peptidomimetics that inhibit TNF alpha binding to its receptor. Nature Biotechnology 15: 1266-1270.
12. Buerke U, Carter JM, Schlitt A, et al. (2008) Apoptosis contributes to septic cardimyopath and is improved by simvstain therapy. Shock 29: 497-503.
13. Steve Lancel, Olivier Joulin, Raphael Favory, et al. (2005) Ventricular myocyte caspases are directly responsible for endotoxin-induced cardiac dysfunction. Circulation 111: 2596-2604.
14. Min Huang, Jing Zhou, Liqing Bi, et al. (2012) Anti-TLR2 antibody, T2. 1, reduces TNF- and IL-6 release and inhibits NF-B expression in bacterial lipoprotein stimulated THP-1 cells. Central Europe Journal of Immunology 37: 6-10.
15. Li XQ, Cao W, Li T, et al. (2009) Amlodipine inhibits TNF production and attenuates cardiac dysfunction induced by lipopolysaccharide involving PI3K/ Akt pathway. International Immunopharmacology 9: 1032-1041.
16. Hua-dong Wang, Xiu-xiu Liu, Da-xiang Lu, et al. (2009) Glycine inhibits the LPS-induced increase in cytosolic Ca2+ concentration and TNF production in cardiomyocytes by activating a glycine receptor. Acta Pharmacologica Sinica 30: 1107-1114.
17. Ulrich Grandel, Ludger Fink, Andreas Blum, et al. (2000) Endotoxin-induced myocardial tumor necrosis factor synthesis depresses contractility of isolated rat hearts: Evidence for a role of sphingosine and cyclooxygenase-2-derived thromboxane production. Circulation 102: 2758-2764.
18. Ting Zhang, Xiangru Lu, Paul Arnold, et al. (2012) Mitogen-activated protein kinase phosphatase-1 inhibits myocardial TNF expression and improves cardiac function during endotoxemia. Cardiovascular Research 93: 471-479.
19. Vander Poll T, Marchant A, Buurman WA, et al. (1995) Endogenous IL-10 protects mice from death during septic peritonitis. Journal of Immunology 155: 5397-5401.
20. Christian Stumpf, Katrin Seybold, Sebastian Petzi, et al. (2008) Interleukin-10 improves left ventricular function in rats with heart failure subsequent to myocardial infarction. European Journal of Heart Failure 10: 733-739.